HUP0203256A2 - Eljárás magas vérnyomás elleni tripeptideket tartalmazó készítmény előállítására - Google Patents

Eljárás magas vérnyomás elleni tripeptideket tartalmazó készítmény előállítására

Info

Publication number
HUP0203256A2
HUP0203256A2 HU0203256A HUP0203256A HUP0203256A2 HU P0203256 A2 HUP0203256 A2 HU P0203256A2 HU 0203256 A HU0203256 A HU 0203256A HU P0203256 A HUP0203256 A HU P0203256A HU P0203256 A2 HUP0203256 A2 HU P0203256A2
Authority
HU
Hungary
Prior art keywords
producing
product containing
containing antihypertensive
subject
tripeptides
Prior art date
Application number
HU0203256A
Other languages
English (en)
Inventor
Annika Mäyrä-Mäkinen
Janne Sahlstein
Tarja Suomalainen
Olli Tossavainen
Original Assignee
Valio Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Valio Ltd. filed Critical Valio Ltd.
Publication of HUP0203256A2 publication Critical patent/HUP0203256A2/hu
Publication of HUP0203256A3 publication Critical patent/HUP0203256A3/hu
Publication of HU226200B1 publication Critical patent/HU226200B1/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/14—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
    • A23C9/142—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration
    • A23C9/1427—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration by dialysis, reverse osmosis or hyperfiltration, e.g. for concentrating or desalting
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
    • A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
    • A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
    • A23J3/341—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins
    • A23J3/343—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins
    • A23J3/344—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins of casein
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A23L2/66—Proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/147—Helveticus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Nutrition Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Water Supply & Treatment (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

A találmány tárgya eljárás vérnyomáscsökkentő peptideket tartalmazókészítmény előállítására kazeintartalmú kiindulási anyagtejsavbaktériumokkal történő erjesztésével. A találmány tárgyát képezitovábbá az előállított készítmény és annak alkalmazása funkcionálistermékként önmagában, vagy alkotóelemként vagy adalékként, közvetlenfogyasztásra alkalmas anyagokban. Ó
HU0203256A 1999-11-01 2000-10-30 Process for producing a product containing antihypertensive tripeptides HU226200B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI992360A FI113741B (fi) 1999-11-01 1999-11-01 Menetelmä verenpainetta alentavia peptidejä sisältävän tuotteen valmistamiseksi
PCT/FI2000/000942 WO2001032905A1 (en) 1999-11-01 2000-10-30 Process for producing a product containing antihypertensive tripeptides

Publications (3)

Publication Number Publication Date
HUP0203256A2 true HUP0203256A2 (hu) 2003-01-28
HUP0203256A3 HUP0203256A3 (en) 2005-11-28
HU226200B1 HU226200B1 (en) 2008-06-30

Family

ID=8555541

Family Applications (2)

Application Number Title Priority Date Filing Date
HU0203185A HUP0203185A3 (en) 1999-11-01 2000-10-30 Lactobacillus helvetius producing antihypertensive di- and tripeptides
HU0203256A HU226200B1 (en) 1999-11-01 2000-10-30 Process for producing a product containing antihypertensive tripeptides

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HU0203185A HUP0203185A3 (en) 1999-11-01 2000-10-30 Lactobacillus helvetius producing antihypertensive di- and tripeptides

Country Status (23)

Country Link
US (2) US6890529B1 (hu)
EP (2) EP1226230B1 (hu)
JP (2) JP3695648B2 (hu)
KR (2) KR100718709B1 (hu)
CN (2) CN1164761C (hu)
AT (2) ATE266735T1 (hu)
AU (2) AU769432B2 (hu)
CA (2) CA2387738C (hu)
CZ (2) CZ294146B6 (hu)
DE (2) DE60010742T2 (hu)
DK (2) DK1226267T3 (hu)
EE (2) EE200200231A (hu)
ES (2) ES2220557T3 (hu)
FI (1) FI113741B (hu)
HR (2) HRP20020378B1 (hu)
HU (2) HUP0203185A3 (hu)
NO (2) NO330951B1 (hu)
NZ (2) NZ518470A (hu)
PL (2) PL364790A1 (hu)
PT (2) PT1226230E (hu)
RU (2) RU2270855C2 (hu)
WO (2) WO2001032836A1 (hu)
ZA (2) ZA200203179B (hu)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI113741B (fi) * 1999-11-01 2004-06-15 Valio Oy Menetelmä verenpainetta alentavia peptidejä sisältävän tuotteen valmistamiseksi
FI112031B (fi) 2002-02-25 2003-10-31 Valio Oy Biologisesti aktiivisen tuotteen uusi käyttö
EP1509609B1 (en) 2002-06-04 2015-04-22 DSM IP Assets B.V. Protein hydrolysate rich in tripeptides
WO2004015125A1 (en) * 2002-08-09 2004-02-19 Chr. Hansen A/S Process for preparing peptides with anti-hypertensive properties
PL378232A1 (pl) * 2003-01-06 2006-03-20 Unilever N.V. Fermentowany produkt mleczny, zawierający tripeptydy VPP i/albo IPP
TWI411441B (zh) * 2003-03-18 2013-10-11 Suntory Holdings Ltd 血管收縮素轉化酶抑制性肽類
US7718171B2 (en) 2003-04-07 2010-05-18 Chr. Hansen A/S Reducing heart rate in mammals using milk derived fermentation products produced using Lactobacillus helveticus
ZA200507880B (en) * 2003-05-05 2006-12-27 Unilever Plc Hydrolysed casein product comprising tripeptides IPP and/or VPP
EP1727440A1 (en) * 2004-03-19 2006-12-06 Campina Nederland Holding B.V. Method of preparing a food ingredient and food product having angiotensin-i-converting enzyme inhibiting properties and products thus obtained
CN101039685B (zh) * 2004-03-31 2010-06-16 卡尔皮斯株式会社 预防、抑制肝病的制剂和预防、抑制肝病的功能食品
US7862808B2 (en) 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
JP4723501B2 (ja) * 2004-07-05 2011-07-13 カルピス株式会社 ペプチド混合物の製造法、抗高血圧ペプチド含有発酵乳の製造法及び抗高血圧ペプチド製剤の製造法
WO2006005757A2 (en) * 2004-07-12 2006-01-19 Dsm Ip Assets B.V. Blood pressure lowering oligopeptides
EP1685764A1 (en) 2005-01-27 2006-08-02 Globus Egg Sciences B.V. Anti-hypertensive functional food products
EP1796480B1 (en) 2004-09-03 2011-11-09 Chr. Hansen A/S Fermented milk proteins comprising receptor ligand and uses thereof
FR2876874B1 (fr) * 2004-10-22 2007-02-16 Gervais Danone Sa Protection d'ingredients alimentaires bioactifs par l'utilisation d'ingredients leurres
FR2876876B1 (fr) * 2004-10-22 2007-02-16 Gervais Danone Sa Protection d'ingredients alimentaires bioactifs par l'utilisation de microorganismes presentant une capacite de metabolisation reduite
CN101084004A (zh) * 2004-12-22 2007-12-05 帝斯曼知识产权资产管理有限公司 单个酶促步骤中的血压降低寡肽
EP1879465A1 (en) * 2005-02-09 2008-01-23 Unilever N.V. Composition comprising peptide
JP5770411B2 (ja) * 2005-02-24 2015-08-26 ディーエスエム アイピー アセッツ ビー．ブイ． グリコマクロペプチド由来の血圧降下ペプチド
US7303745B2 (en) 2005-04-15 2007-12-04 Bristol-Myers Squibb Company Method for preventing or treating the development of respiratory allergies
ES2755775T3 (es) * 2005-11-28 2020-04-23 Dsm Ip Assets Bv Preparación de enzima que produce un sabor puro
CA2642539C (en) * 2006-02-14 2013-01-08 Calpis Co., Ltd. Agent for preventing arteriosclerosis, agent for suppressing vascular intimal thickening and agent for improving vascular endothelial function
EA200870259A1 (ru) * 2006-02-14 2009-02-27 Калпис Ко., Лтд. Сосудорасширяющее средство
ATE423840T1 (de) * 2006-02-20 2009-03-15 Gervais Danone Sa Neue stämme von lactobacillus helveticus
DE602006004956D1 (de) * 2006-02-20 2009-03-12 Gervais Danone Sa Neue Stämme von Lactobacillus helveticus
PL1820851T3 (pl) * 2006-02-20 2012-07-31 Gervais Danone Sa Szczepy Lactobacillus helveticus nie fermentujące laktozy
CN100370019C (zh) * 2006-04-21 2008-02-20 江南大学 一种具有抗高血压作用的植物乳杆菌cw006
RU2457852C2 (ru) * 2006-05-15 2012-08-10 Валио Лтд Новое применение терапевтически эффективных пептидов
US20090111758A1 (en) * 2006-05-15 2009-04-30 Valio Ltd. Use of therapeutically useful peptides
NZ575469A (en) * 2006-09-04 2012-05-25 Megmilk Snow Brand Co Ltd Agent comprising lactobacillus for accelerating the increase in and/or preventing the decrease in blood adiponectin level, and visceral fat accumulation inhibitor
PT1915913E (pt) 2006-10-23 2016-02-16 Nestec Sa Modulação do sabor e do aroma de produtos lácteos por biotransformação
ES2351230T3 (es) * 2007-02-02 2011-02-01 May, Amadeus Alexander Producto con microorganismos prebióticos vivos.
US10842813B2 (en) 2007-02-26 2020-11-24 Heartbeet Ltd Compositions of nitrates and methods of use thereof
US11759477B2 (en) 2007-02-26 2023-09-19 Heartbeet Ltd. Compositions of nitrates and methods of use thereof
BRPI0809319A2 (pt) * 2007-03-27 2014-09-23 Calpis Co Ltd Agente para suprimir espessamento de parede de coração, agente profilático para hipertrofia cardíaca, agente profilático para insuficiência cardíaca, e, alimento funcional
MX2010013781A (es) * 2008-06-12 2010-12-21 Nestec Sa Cadenas de lactobacillus helveticus para producir peptidos hipotensivos.
DE102008032828A1 (de) 2008-07-02 2010-01-07 Technische Universität Dresden Tryptophanhaltige Peptide aus alpha-Lactalbumin mit blutdrucksenkender und vasoprotektiver Wirkung für biofunktionelle Lebensmittel
FI122531B (fi) * 2009-09-30 2012-03-15 Valio Oy Juusto ja menetelmä sen valmistamiseksi
RU2453593C1 (ru) * 2011-04-21 2012-06-20 Общество с ограниченной ответственностью "Бифилюкс" Штамм lactobacillus helveticus, используемый для получения продукции, содержащей лактобактерии
CN102786579B (zh) * 2012-07-17 2014-07-09 上海交通大学 抗高血压活性肽vip
CN102786580A (zh) * 2012-07-17 2012-11-21 上海交通大学 抗高血压活性肽ivp
RU2580052C1 (ru) * 2014-12-24 2016-04-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Горский государственный аграрный университет" Штамм lactobacillus helveticus вкпм в-11176, полученный на доступных питательных средах
RU2577112C1 (ru) * 2014-12-25 2016-03-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Горский государственный аграрный университет" Штамм lactobacillus helveticus вкпм в-11175, полученный на доступных питательных средах
PL3547841T3 (pl) 2016-12-02 2021-05-17 Fairlife, Llc Nie ulegający brązowieniu wolny od laktozy proszek mleczny oraz sposoby jego wytwarzania
RU2685912C1 (ru) * 2018-03-14 2019-04-23 Федеральное государственное автономное научное учреждение "Научно-исследовательский институт хлебопекарной промышленности" Штамм бактерий lactobacillus amylolyticus, используемый для приготовления термофильной заквашенной заварки
RU2728171C2 (ru) * 2018-11-08 2020-07-28 Общество с ограниченной ответственностью "Инновационные биотехнологии" (ООО "Инбиотех") Штамм бактерий Lactobacillus helveticus T-5068, используемый в качестве закваски прямого внесения для приготовления кисломолочных продуктов
CN109517763B (zh) * 2018-12-27 2022-03-22 内蒙古农业大学 瑞士乳杆菌h11及其应用
TWI713972B (zh) * 2019-01-14 2020-12-21 大江生醫股份有限公司 改善呼吸道健康之益生菌株及其組合物與用途
WO2021195718A1 (en) * 2020-04-02 2021-10-07 Ahtesh Fatah Bashir Milk fermentation process
CN112029784A (zh) * 2020-09-16 2020-12-04 内蒙古农业大学 一个与蛋白水解能力相关的基因及基于该基因的高蛋白水解能力瑞士乳杆菌的筛选方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2483748A1 (fr) * 1980-06-06 1981-12-11 Corning Glass Works Procede d'hydrolyse du lactose contenu dans les lactoserums a l'aide de lactase immobilisee
JPS6153216A (ja) 1984-08-23 1986-03-17 Rikagaku Kenkyusho 高血圧症予防治療剤
JP2782142B2 (ja) * 1992-07-23 1998-07-30 カルピス株式会社 アンジオテンシン変換酵素阻害剤及びその製造法
JP2782153B2 (ja) 1992-11-09 1998-07-30 カルピス株式会社 アンジオテンシン変換酵素阻害ペプチドの製造法
JP2824821B2 (ja) 1993-11-04 1998-11-18 カルピス株式会社 乳酸菌及び発酵乳製品
GB2294191B (en) 1994-10-06 1997-10-01 Waterford Creamery Ltd Cheese manufacture
JP3782837B2 (ja) 1995-04-10 2006-06-07 カルピス株式会社 血圧降下剤及びその製造法
JPH09188694A (ja) 1996-01-10 1997-07-22 Otsuka Shokuhin Kk ペプチド、アンジオテンシン変換酵素阻害組成物及びその製法
JP3746556B2 (ja) 1996-02-09 2006-02-15 カルピス株式会社 プラスミド及びプラスミドベクター
US5854029A (en) 1996-08-02 1998-12-29 Calpis Co., Ltd. Method for preparing antihypertensive agent
JP4727770B2 (ja) * 1997-09-26 2011-07-20 カルピス株式会社 尿中カテコールアミン低下、尿中ノルアドレナリン低下、尿中ドーパミン低下及びＦｉｓｃｈｅｒ比低下の少なくとも１つの軽減剤
JP3028411B2 (ja) 1997-09-26 2000-04-04 カルピス株式会社 トリペプチド高生産性ラクトバチルス・ヘルベチカス乳酸菌
FI104783B (fi) 1998-02-12 2000-04-14 Valio Oy Herasuolajauhe, menetelmä sen valmistamiseksi ja sen käyttö
FI113741B (fi) * 1999-11-01 2004-06-15 Valio Oy Menetelmä verenpainetta alentavia peptidejä sisältävän tuotteen valmistamiseksi
US6514941B1 (en) * 1999-12-10 2003-02-04 Campina Melkunie B.V. Method of preparing a casein hydrolysate enriched in anti-hypertensive peptides

Also Published As

Publication number Publication date
HRP20020378B1 (en) 2005-06-30
EE05461B1 (et) 2011-08-15
EE200200231A (xx) 2003-06-16
DE60016959T2 (de) 2005-12-22
JP3695648B2 (ja) 2005-09-14
NO20022061L (no) 2002-06-28
FI19992360A (fi) 2001-05-02
CN1197956C (zh) 2005-04-20
EP1226230A1 (en) 2002-07-31
AU1149801A (en) 2001-05-14
ZA200203179B (en) 2003-07-22
CZ20021431A3 (cs) 2002-08-14
AU769432B2 (en) 2004-01-29
CA2388354A1 (en) 2001-05-10
US6890529B1 (en) 2005-05-10
ATE285470T1 (de) 2005-01-15
DE60010742T2 (de) 2005-05-12
CN1387577A (zh) 2002-12-25
NO20022062L (no) 2002-06-28
WO2001032836A1 (en) 2001-05-10
CN1387564A (zh) 2002-12-25
HUP0203185A2 (hu) 2003-01-28
HRP20020377A2 (en) 2003-08-31
HU226200B1 (en) 2008-06-30
KR100704441B1 (ko) 2007-04-24
HRP20020377B1 (en) 2005-06-30
EP1226267B1 (en) 2004-05-12
DK1226267T3 (da) 2004-09-20
DK1226230T3 (da) 2005-04-04
DE60016959D1 (de) 2005-01-27
NO20022062D0 (no) 2002-04-30
RU2270855C2 (ru) 2006-02-27
JP2003513621A (ja) 2003-04-15
HUP0203185A3 (en) 2005-07-28
US6972282B1 (en) 2005-12-06
HUP0203256A3 (en) 2005-11-28
CZ20021369A3 (cs) 2002-07-17
KR20020064895A (ko) 2002-08-10
JP2003513636A (ja) 2003-04-15
PT1226267E (pt) 2004-08-31
PT1226230E (pt) 2005-04-29
CN1164761C (zh) 2004-09-01
PL364790A1 (en) 2004-12-13
HRP20020378A2 (en) 2003-08-31
EE200200230A (et) 2003-06-16
JP4172681B2 (ja) 2008-10-29
CZ302271B6 (cs) 2011-01-19
WO2001032905A1 (en) 2001-05-10
NZ518470A (en) 2003-03-28
PL355670A1 (en) 2004-05-04
ZA200203172B (en) 2003-09-23
KR20020060220A (ko) 2002-07-16
NZ518493A (en) 2003-03-28
ES2220557T3 (es) 2004-12-16
EP1226267A1 (en) 2002-07-31
ES2234686T3 (es) 2005-07-01
CZ294146B6 (cs) 2004-10-13
AU1149901A (en) 2001-05-14
ATE266735T1 (de) 2004-05-15
NO20022061D0 (no) 2002-04-30
AU777795B2 (en) 2004-10-28
PL204119B1 (pl) 2009-12-31
NO330951B1 (no) 2011-08-22
DE60010742D1 (de) 2004-06-17
CA2387738A1 (en) 2001-05-10
EP1226230B1 (en) 2004-12-22
RU2276689C2 (ru) 2006-05-20
FI113741B (fi) 2004-06-15
KR100718709B1 (ko) 2007-05-16
CA2387738C (en) 2008-09-16

Similar Documents

Publication Publication Date Title
HUP0203256A2 (hu) Eljárás magas vérnyomás elleni tripeptideket tartalmazó készítmény előállítására
ATE493502T1 (de) Glucosamin und verfahren zur herstellung von glucosamin aus mikrobieller biomasse
IL151338A0 (en) Cultured protein hydrolysate
ATE303070T1 (de) Herstellung von nahrungsmitteln durch fermentierung von sojamilch mit streptococcus thermophilus
DE10390418D2 (de) Verfahren zur Herstellung von rekombinanten Proteinen in Mikroorganismen
AU2003235874A1 (en) Skin collagen production promoter
AP1433A (en) Baking mixes which contain flour and have an enhanced shelf life and method and means of preparing same.
FI945453A (fi) Hiivatuotteiden valmistus laktoosia sisältävistä substraateista
DE69836141D1 (de) Verfahren und zusammensetzungen zur reduzierung des bierverderbs
TW200511935A (en) Composition with heart rate reducing properties
DE60016421D1 (de) Verfahren zur herstellung eines gärungsprodukts
PL1687014T3 (pl) Zastosowanie dodatkowo przefermentowanego wywaru zbożowego do zapobiegania i/lub leczenia podwyższonych wartości cukru we krwi
RU2000116113A (ru) Способ получения бактериальной закваски для кисломолочного продукта
ATE376361T1 (de) Fermentiertes, sojaproteine enthaltendes lebensmittel
BG108541A (en) Bread products of higher biological values

Legal Events

Date Code Title Description
MM4A Lapse of definitive patent protection due to non-payment of fees